Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Central Sleep Apnea: early-phase trial registry
A small indexed set (5 trials) with no open enrollment listed right now.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count
Central Sleep Apnea: 5 US clinical trials tracked, none currently recruiting.
Central Sleep Apnea is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Respicardia, running 2 of these trials.
Enrollment posture brief
Registry condition central-sleep-apnea
OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Central Sleep Apnea has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Central Sleep Apnea on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Central Sleep Apnea is recruiting below its size-band peers.
0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Central Sleep Apnea research.
Respicardia accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Central Sleep Apnea trials plan to enrol fewer than 100 people.
Median target enrolment is 92 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
Central Sleep Apnea research leans observational.
2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
5 total, page 1 of 1
remedē System Therapy Study
Respicardia
NCT03884660
Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing
Somnarus
NCT02034175
A Multi-Center Study to Assess the Performance of Saturation Patterns.
Medtronic - MITG
NCT00775346
Post Approval Study of the remedē System
Respicardia
NCT03425188
Managing Opioid Related Sleep Apnea With Acetazolamide
University of California, San Diego
NCT06043830
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Central Sleep Apnea records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Central Sleep Apnea trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Central Sleep Apnea page
5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Central Sleep Apnea trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Respicardia sponsors the most Central Sleep Apnea trials on record, review their full trial history before evaluating a specific study. See Respicardia's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Central Sleep Apnea condition card totals 5 registered trials; most-linked intervention SomnaPatch; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.